| 标题 |
Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:P. Schmid; H.-C. Wang; F. Lynce; J. Asselah; K.H. Jung; et al 出版日期:2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)